{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:03:56Z","timestamp":1785413036545,"version":"3.56.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To investigate dynamic changes in aqueous humor cytokines and retinal vessel density during aflibercept loading in treatment-naive neovascular age-related macular degeneration (nAMD), and to analyze their associations with visual improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This single-center retrospective clinical study included 20 treatment-naive patients with nAMD (20 eyes) and 20 patients with cataracts (20 eyes). In the nAMD group, aqueous humor samples were collected at baseline and at the time of the third intravitreal aflibercept injection, while samples from the cataract control group were obtained before surgery. Relevant aqueous humor cytokines were measured using the Bio-Plex suspension bead array system. In the nAMD group, best-corrected visual acuity (BCVA) and optical coherence tomography angiography (OCTA) examinations were performed at baseline and at 1 and 2 months after treatment. Longitudinal changes in OCTA parameters were analyzed using mixed-effects models, followed by correlation analyses. According to the final BCVA outcome, eyes in the nAMD group were further classified into an obvious-improvement group and a non-obvious-improvement group for exploratory subgroup comparison.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared with the cataract control group, eyes with nAMD showed significant differences in baseline aqueous humor levels of Ang-2, HGF, VEGF-C, IP-10, HB-EGF, IL-8, and PlGF. During aflibercept loading, aqueous humor levels of Ang-2, HGF, and IP-10 increased, whereas IL-8 decreased. At month 2, the superficial parafoveal vessel density and the superficial and deep perifoveal vessel density decreased significantly compared with baseline, while BCVA improved significantly. Baseline Ang-2, bFGF, and IL-8 showed nominal exploratory associations with OCTA changes, but these associations did not remain significant after FDR correction. In subgroup analysis of the nAMD cohort, only the change in deep perifoveal vessel density differed significantly between the obvious-improvement group and the non-obvious-improvement group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Treatment-naive nAMD eyes exhibited differential changes in aqueous humor cytokines during aflibercept loading, consistent with possible non-VEGF pathway involvement. Meanwhile, regional remodeling of retinal microcirculation was observed, and changes in deep perifoveal vessel density showed a trend consistent with short-term visual improvement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1857826","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:10:30Z","timestamp":1785409830000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Dynamic changes in aqueous humor cytokines and OCTA parameters during aflibercept loading in treatment-naive neovascular age-related macular degeneration"],"prefix":"10.3389","volume":"13","author":[{"given":"Chenwei","family":"Gui","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialong","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanxi Eye Hospital Affiliated to Shanxi Medical University, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","article-title":"Age-related macular degeneration.","volume":"401","author":"Guymer","year":"2023","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2147\/OPTH.S409103","article-title":"Through the eyes of patients: understanding treatment burden of intravitreal anti-VEGF injections for nAMD patients in Norway.","volume":"17","author":"Reitan","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41433-022-02020-7","article-title":"Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis.","volume":"37","author":"Rosenberg","year":"2023","journal-title":"Eye"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e001516","DOI":"10.1136\/bmjophth-2023-001516","article-title":"Neovascular age-related macular degeneration: disease pathogenesis and current state of molecular biomarkers predicting treatment response-a scoping review.","volume":"9","author":"Dervenis","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s12886-021-02152-6","article-title":"Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients.","volume":"21","author":"Joo","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e144469","DOI":"10.1172\/JCI144469","article-title":"Aqueous proteins help predict the response of patients with neovascular age-related macular degeneration to anti-VEGF therapy.","volume":"132","author":"Cao","year":"2022","journal-title":"J Clin Invest"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/IAE.0000000000003003","article-title":"THE ANGIOPOIETIN\/TIE PATHWAY IN RETINAL VASCULAR DISEASES: a review.","volume":"41","author":"Heier","year":"2021","journal-title":"Retina"},{"key":"B8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology.","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/s41433-020-01377-x","article-title":"Angiopoietin\/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data.","volume":"35","author":"Joussen","year":"2021","journal-title":"Eye"},{"key":"B10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","article-title":"Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.","volume":"399","author":"Heier","year":"2022","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1007\/s00417-024-06531-9","article-title":"Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.","volume":"262","author":"Agostini","year":"2024","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"973025","DOI":"10.3389\/fmed.2022.973025","article-title":"Association between inflammatory cytokines in the aqueous humor and hyperreflective foci on optical coherence tomography in patients with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy.","volume":"9","author":"Mao","year":"2022","journal-title":"Front Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0229342","DOI":"10.1371\/journal.pone.0229342","article-title":"Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration.","volume":"15","author":"Arai","year":"2020","journal-title":"PLoS One"},{"key":"B14","doi-asserted-by":"publisher","first-page":"19447","DOI":"10.1038\/s41598-019-55191-x","article-title":"Comprehensive expression patterns of inflammatory cytokines in aqueous humor of patients with neovascular age-related macular degeneration.","volume":"9","author":"Sato","year":"2019","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/iovs.65.11.37","article-title":"Poor response to bevacizumab correlates with higher IL-6 and IL-8 aqueous cytokines in AMD.","volume":"65","author":"Connolly","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/s41598-018-19594-6","article-title":"Intraocular inflammatory cytokines in patients with neovascular age-related macular degeneration before and after initiation of intravitreal injection of anti-VEGF inhibitor.","volume":"8","author":"Sato","year":"2018","journal-title":"Sci Rep"},{"key":"B17","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.3390\/jcm13175042","article-title":"Overview of the use of optical coherence tomography angiography in neovascular age-related macular degeneration.","volume":"13","author":"Faatz","year":"2024","journal-title":"J Clin Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.survophthal.2023.02.004","article-title":"Practical guidance for imaging biomarkers in exudative age-related macular degeneration.","volume":"68","author":"Rispoli","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"18068","DOI":"10.1038\/s41598-021-97652-2","article-title":"Combined quantitative and qualitative optical coherence tomography angiography biomarkers for predicting active neovascular age-related macular degeneration.","volume":"11","author":"Hsu","year":"2021","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajo.2024.06.019","article-title":"Analyzing formation and absorption of avascular subretinal hyperreflective material in nAMD From OCTA-based insights.","volume":"267","author":"Pu","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"31951","DOI":"10.1038\/s41598-024-83473-6","article-title":"Analysis of the aqueous humor before and after the administration of faricimab in patients with nAMD.","volume":"14","author":"Nonogaki","year":"2024","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1167\/iovs.65.11.15","article-title":"Aqueous humor cytokine analysis in age-related macular degeneration after switching from aflibercept to faricimab.","volume":"65","author":"Todoroki","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"45081","DOI":"10.1038\/srep45081","article-title":"Elevated angiopoietin 2 in aqueous of patients with neovascular age related macular degeneration correlates with disease severity at presentation.","volume":"7","author":"Ng","year":"2017","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12886-024-03614-3","article-title":"Aqueous humor cytokine levels in patients with subretinal fibrosis in neovascular age-related macular degeneration.","volume":"24","author":"Cao","year":"2024","journal-title":"BMC Ophthalmol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/ATVBAHA.117.310337","article-title":"Both autocrine signaling and paracrine signaling of HB-EGF enhance ocular neovascularization.","volume":"38","author":"Inoue","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e44937","DOI":"10.1371\/journal.pone.0044937","article-title":"Enhanced PKC\u03b4 and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF.","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/01.RES.0000209968.66606.10","article-title":"IP-10 blocks vascular endothelial growth factor-induced endothelial cell motility and tube formation via inhibition of calpain.","volume":"98","author":"Bodnar","year":"2006","journal-title":"Circ Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12974-024-03265-7","article-title":"Ganglion cell-derived LysoPS induces retinal neovascularisation by activating the microglial GPR34-PI3K-AKT-NINJ1 axis.","volume":"21","author":"Chen","year":"2024","journal-title":"J Neuroinflammation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s40123-024-00973-4","article-title":"Vascular endothelial growth factor C and D signaling pathways as potential targets for the treatment of neovascular age-related macular degeneration: a narrative review.","volume":"13","author":"Leitch","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"B30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12950-018-0203-x","article-title":"Dynamics of soluble vascular endothelial growth factor receptors and their ligands in aqueous humour during ranibizumab for age-related macular degeneration.","volume":"15","author":"Motohashi","year":"2018","journal-title":"J Inflamm"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e869","DOI":"10.1111\/aos.14691","article-title":"Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanism.","volume":"99","author":"Angermann","year":"2021","journal-title":"Acta Ophthalmol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.oret.2017.04.004","article-title":"Bevacizumab injection in patients with neovascular age-related macular degeneration increases angiogenic biomarkers.","volume":"2","author":"Cabral","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"B33","doi-asserted-by":"publisher","first-page":"594087","DOI":"10.3389\/fphar.2020.594087","article-title":"Molecular biomarkers of neovascular age-related macular degeneration with incomplete response to anti-vascular endothelial growth factor treatment.","volume":"11","author":"Mantel","year":"2020","journal-title":"Front Pharmacol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"100906","DOI":"10.1016\/j.preteyeres.2020.100906","article-title":"Incomplete response to Anti-VEGF therapy in neovascular AMD: exploring disease mechanisms and therapeutic opportunities.","volume":"82","author":"Mettu","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41433-024-03015-2","article-title":"Aqueous humour interleukin-6 and vision outcomes with anti-vascular endothelial growth factor therapy.","volume":"38","author":"Sepah","year":"2024","journal-title":"Eye"},{"key":"B36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40662-022-00287-1","article-title":"Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography.","volume":"9","author":"Jia","year":"2022","journal-title":"Eye Vis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.3390\/diagnostics12112807","article-title":"The architecture of macular neovascularizations predicts treatment responses to anti-VEGF therapy in neovascular AMD.","volume":"12","author":"Faatz","year":"2022","journal-title":"Diagnostics"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1857826\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:10:31Z","timestamp":1785409831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1857826\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":37,"alternative-id":["10.3389\/fmed.2026.1857826"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1857826","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"article-number":"1857826"}}